<SEC-DOCUMENT>0000950170-24-055055.txt : 20240508
<SEC-HEADER>0000950170-24-055055.hdr.sgml : 20240508
<ACCEPTANCE-DATETIME>20240508070511
ACCESSION NUMBER:		0000950170-24-055055
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240508
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240508
DATE AS OF CHANGE:		20240508

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EyePoint Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001314102
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				262774444
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51122
		FILM NUMBER:		24924206

	BUSINESS ADDRESS:	
		STREET 1:		480 PLEASANT STREET
		STREET 2:		SUITE B300
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472
		BUSINESS PHONE:		617-926-5000

	MAIL ADDRESS:	
		STREET 1:		480 PLEASANT STREET
		STREET 2:		SUITE B300
		CITY:			WATERTOWN
		STATE:			MA
		ZIP:			02472

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	pSivida Corp.
		DATE OF NAME CHANGE:	20080619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	pSivida LTD
		DATE OF NAME CHANGE:	20050111
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>eypt-20240508.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-05-07T18:19:23.7740+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:eypt="http://eyepointpharma.com/20240508">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_07502e19-034f-4e84-b7dc-e88619825f3a" name="dei:EntityCentralIndexKey" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce">0001314102</ix:nonNumeric><ix:nonNumeric id="F_7fa45e2a-6039-44c6-87e7-8d5516872c03" name="dei:AmendmentFlag" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="eypt-20240508.xsd"/></ix:references><ix:resources><xbrli:context id="C_5180bc99-5889-4922-9124-48a80e5659ce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001314102</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-08</xbrli:startDate><xbrli:endDate>2024-05-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="min-height:0.5in;"></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_558eae15-2714-42e0-8d78-6d5943c628cb" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_0eaf18ad-fc07-4612-9f2e-77c68199b5ac" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">May 08, 2024</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c2d5b467-e2da-4b97-b16a-87be4f688284" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">EyePoint Pharmaceuticals, Inc.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;"/>
    <td style="width:1%;"/>
    <td style="width:20%;"/>
    <td style="width:18%;"/>
    <td style="width:41%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c015c280-1d5a-4227-9de6-0f926a37802f" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_1a4721f6-528c-45e3-a314-c1d2e0da2a95" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">000-51122</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_71b400c7-e391-4a86-82ac-312c02100bab" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">26-2774444</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_ce19a4dd-648b-4886-8591-8d87ff61c534" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">480 Pleasant Street</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_51d5d8d9-fd9f-43b9-b380-29e8bdc39764" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Watertown</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_e73be44e-6b9a-4250-983f-d76d0cba35ea" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Massachusetts</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_5997b360-fdcb-40ac-8a4b-317b229d3ae8" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">02472</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_61645bdb-b121-4fd9-8d00-9a5acfc554f7" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(617)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_d8b40ce1-0f3d-443c-a3ad-f6f58fc8d34f" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">926-5000</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"/>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ec882b33-250a-4df0-b267-e19bde563650" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_970f4e72-dc4c-4f90-9627-66c58e848cdd" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_22baf61e-a314-4705-b492-dcae7c488f7d" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_67a7a27b-2231-41ff-a2f5-b34d81f0a7ae" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;"/>
    <td style="width:1%;"/>
    <td style="width:15%;"/>
    <td style="width:1%;"/>
    <td style="width:45%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_15ed3447-150f-4cd7-af1d-7f9433989da8" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common Stock, par value $0.001</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e0c124fe-e502-4e6f-b030-d225473db40f" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">EYPT</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_5e9bd01b-00e2-4ef5-90be-5278b760d59f" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Nasdaq Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_62de7fd1-fcec-4184-99b7-8505958509fa" contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 8, 2024, EyePoint Pharmaceuticals, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the quarter ended March 31, 2024 and certain other information. A copy of the press release is furnished as Exhibit 99.1 hereto.</span></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.94%;"/>
    <td style="width:1%;"/>
    <td style="width:89.06%;"/>
   </tr>
   <tr style="height:8pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;border-bottom:1pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Exhibit No.</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-left:0.01in;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid #000000;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">99.1</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="eypt-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Press Release of EyePoint Pharmaceuticals, Inc., dated May 8, 2024</span></a></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover Page Interactive Data File (embedded within the inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;"/>
  <div style="min-height:0.5in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:4.533%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6%;"/>
    <td style="width:44%;"/>
    <td style="width:4%;"/>
    <td style="width:46%;"/>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">EYEPOINT PHARMACEUTICALS, INC.</span></p></td>
   </tr>
   <tr style="word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Date:</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">May 8, 2024</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ George O. Elston</span></p></td>
   </tr>
   <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">George O. Elston<br/>Executive Vice President and Chief Financial Officer</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>eypt-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img96707757_0.jpg" alt="img96707757_0.jpg" style="width:231px;height:45px;">&#160;</p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">                                       	Exhibit 99.1</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">                                                                                                                              </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2013;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Company on track to initiate the Phase 3 LUGANO pivotal non-inferiority trial of DURAVYU</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">&#153;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> in wet AMD in 2H 2024 &#x2013;</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">&#x2013; $299 million of cash and investments on March 31, 2024, with cash runway through topline data of Phase 3 trials for DURAVYU for wet AMD in 2026 &#x2013;</font></p>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:center;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">&#x2013;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Company to host R&amp;D Day in New York on June 26, 2024 &#x2013;</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">WATERTOWN, Mass., May 8, 2024 (GLOBE NEWSWIRE) &#x2013; EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced financial results for the first quarter ended March 31, 2024, and highlighted recent corporate developments.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#x201c;We have continued advancing our pipeline through significant milestones including the announcement of topline data from our Phase 2 PAVIA clinical trial of DURAVYU</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">&#153;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> in non-proliferative diabetic retinopathy (NPDR),&#x201d; said Jay Duker, M.D., President and Chief Executive Officer of EyePoint Pharmaceuticals. &#x201c;Although the PAVIA trial did not meet the pre-specified primary endpoint, we were encouraged that DURAVYU demonstrated a biologic effect in patients with NPDR and continues to show a favorable safety and tolerability profile. As such, we plan to assess the full twelve-month study results once they are available to evaluate the path forward for DURAVYU as a potential treatment for NPDR. Looking ahead, we remain on track to initiate the first pivotal Phase 3 LUGANO non-inferiority clinical trial of DURAVYU in wet AMD in the second half of 2024 and for topline data for the Phase 2 VERONA trial in diabetic macular edema (DME) in the first quarter of 2025.&#x201d;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">R&amp;D Highlights and Updates</font></p>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Announced topline efficacy and safety data from the Phase 2 PAVIA clinical trial of DURAVYU in NPDR in May. The data demonstrated that DURAVYU has a biologic effect in patients with NPDR with a favorable safety and tolerability profile; however, the trial did not meet the pre-specified primary endpoint. The Company plans to provide an update on the path forward for DURAVYU as a potential treatment in NPDR following a review of the full 12-month data in the third quarter of 2024.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Completed an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) in April to discuss pivotal Phase 3 clinical trial plans for DURAVYU in wet AMD. The Company will provide an update once final meeting minutes are received from the FDA.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Presented the science and supporting clinical data for DURAVYU as a potentially disruptive innovation in the management of patients with wet AMD at the Ophthalmology Innovation Summit (OIS) Retina in May. Additionally, EyePoint was accepted to participate in a panel discussion at the Retina World Congress where the Company also plans to present an encore presentation of the DAVIO 2 clinical trial results. </font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Presented four posters at the 2024 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in May highlighting the durable efficacy, reliable safety, and reduced injection burden of treatment with DURAVYU. The topics presented include plasma PK data of single-and repeat-dose of DURAVYU, the mechanism of action of vorolanib and differentiation versus other </font></div></div>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img96707757_0.jpg" alt="img96707757_0.jpg" style="width:231px;height:45px;">&#160;</p></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.333%;visibility:hidden;display:inline-flex;justify-content:flex-start;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">tyrosine kinase inhibitors, the design and function of DURAVYU as a sustained delivery platform for retinal disease, and an encore presentation of DAVIO 2 clinical trial results.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Published Phase 1 DAVIO trial results in Ophthalmology Science in April, in article entitled, &#x201c;Phase 1 DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients with Wet Age-related Macular Degeneration&#x201d; (DOI: https://doi.org/10.1016/j.xops.2024.100527).</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Expanded the Company&#x2019;s Scientific Advisory Board with world-renowned retina specialists including Usha Chakravarthy, M.B.B.S., Ph.D.; Allen Ho, M.D. FACS FASRS, and Frank Holz, M.D., F.E.B.O., F.A.R.V.O. to support advancement of the Company&#x2019;s global clinical strategy for DURAVYU ahead of the anticipated initiation of its Phase 3 pivotal trials in wet AMD. Additionally, Charles Wykoff, M.D., Ph.D. joined Carl Regillo, M.D., FACS as co-chair of Scientific Advisory Board.</font></div></div>
  <div style="display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.333%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">EyePoint plans to host an R&amp;D Day on June 26, 2024 in New York City. The event will feature commentary from management and KOL guest speakers. They will discuss the science behind EyePoint&#x2019;s bioerodible Durasert E&#153; technology and the clinical and regulatory progress for their lead pipeline asset, DURAVYU, as well as an overview of the Company&#x2019;s early pipeline programs. Additional details for the R&amp;D Day to follow. KOL guest speakers include:</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">o</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Yasha S. Modi, M.D.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, Associate Professor of Vitreoretinal Surgery, Retinal Disease and Uveitis at New York University; Director of Teleretina</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">o</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Carl Regillo M.D.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, FACS Professor of Ophthalmology at Thomas Jefferson University; Chief of Retina Service at Wills Eye Hospital; Founder of Wills Eye Clinical Retina Research Unit in Philadelphia</font></div></div>
  <div style="margin-left:6.667%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:3.571084182443509%;display:inline-flex;justify-content:flex-start;">o</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Rishi P. Singh M.D.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">, Staff Physician, Vice-President and Chief Medical Officer of the Cleveland Clinical Martin Hospitals, Cleveland Clinic Florida, Stuart FL</font></div></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Review of Results for the First Quarter Ended March 31, 2024</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">For the first quarter ended March 31, 2024, total net revenue was $11.7 million compared to $7.7 million for the quarter ended March 31, 2023. Net product revenue for the first quarter was $0.7 million, compared to net product revenues for the first quarter ended March 31, 2023 of $7.4 million. This decrease in net product revenue resulted from the out-license of the YUTIQ franchise in May 2023, completing the strategic pivot from a commercial company to a biopharmaceutical pipeline-focused company.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Net revenue from royalties and collaborations for the first quarter ended March 31, 2024 totaled $11.0 million compared to $0.3 million in the corresponding period in 2023. This increase was primarily due to partial recognition of deferred revenue from the license of the YUTIQ franchise, which begun in 2Q 2023 and will be recognized over a 2-year period in connection with the delivery of YUTIQ supply units.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Operating expenses for the first quarter ended March 31, 2024 totaled $45.0 million versus $29.2 million in the prior year period. This increase was primarily driven by significant growth in research and development costs, including DURAVYU clinical trial activities and personnel expenses, and stock-based compensation offset by reduced sales and marketing expense from the exit of our commercial business in 1H 2023. Non-operating income, net, totaled $4.0 million and net loss was $29.3 million, or ($0.55) per share, compared to a net loss of $21.2 million, or ($0.56) per share, for the prior year period.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img96707757_0.jpg" alt="img96707757_0.jpg" style="width:231px;height:45px;">&#160;</p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Cash and investments at March 31, 2024 totaled $299.3 million compared to $331.0 million at December 31, 2023.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Financial Outlook</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"><br>We expect the cash, cash equivalents and investments on March 31, 2024, will enable us to fund operations through topline data for the planned Phase 3 clinical trials of DURAVYU for wet AMD in 2026.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">DURAVYU&#153; has been conditionally accepted by the FDA as the proprietary name for EYP-1901. DURAVYU is an investigational product; it has not been approved by the FDA. FDA approval and the timeline for potential approval is uncertain.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">About EyePoint Pharmaceuticals</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">EyePoint Pharmaceuticals (Nasdaq: EYPT) is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases. The Company's pipeline leverages its proprietary bioerodible Durasert E</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">&#153;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> technology for sustained intraocular drug delivery. The Company&#x2019;s lead product candidate, DURAVYU (previously known as EYP-1901), is an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E&#153;. Pipeline programs include EYP-2301, a promising TIE-2 agonist, razuprotafib, formulated in Durasert E</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">&#153;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> to potentially improve outcomes in serious retinal diseases. The proven Durasert</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">&#174;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> drug delivery technology has been safely administered to thousands of patient eyes across four U.S. FDA approved products. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Vorolanib is licensed to EyePoint exclusively by Equinox Sciences, a Betta Pharmaceuticals affiliate, for the localized treatment of all ophthalmic diseases outside of China, Macao, Hong Kong and Taiwan.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Forward Looking Statements</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">EYEPOINT PHARMACEUTICALS SAFE HARBOR STATEMENTS UNDER THE PRIVATE SECURITIES LITIGATION ACT OF 1995: To the extent any statements made in this press release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding the use of proceeds for the offering and other statements identified by words such as &#x201c;will,&#x201d; &#x201c;potential,&#x201d; &#x201c;could,&#x201d; &#x201c;can,&#x201d; &#x201c;believe,&#x201d; &#x201c;intends,&#x201d; &#x201c;continue,&#x201d; &#x201c;plans,&#x201d; &#x201c;expects,&#x201d; &#x201c;anticipates,&#x201d; &#x201c;estimates,&#x201d; &#x201c;may,&#x201d; other words of similar meaning or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause EyePoint&#x2019;s actual results to be materially different than those expressed in or implied by EyePoint&#x2019;s forward-looking statements. For EyePoint, this includes statements about the sufficiency of our existing cash resources through topline data for Phase 3 clinical trials for EYP-1901 (DURAVYU</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Times New Roman;min-width:fit-content;">&#153;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">) in wet AMD; our expectations regarding the timing and clinical development of our product candidates, including DURAVYU and EYP-2301; the potential for DURAVYU as a novel sustained delivery treatment for serious eye diseases, including wet age-related macular degeneration (wet AMD) and non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema (DME); the effectiveness and timeliness of clinical trials, and the usefulness of the data; the timeliness of regulatory approvals including potential U.S. Food and Drug Administration (FDA) regulatory approval of DURAVYU and EYP-2301; the success of current and future license agreements; our dependence on contract research organizations, co-promotion partners, and other outside vendors and service providers; the success of Durasert&#174; as a drug delivery platform in FDA approved products; product liability; industry consolidation; compliance with environmental laws; risks and costs of international business operations; volatility of stock price; possible</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img96707757_0.jpg" alt="img96707757_0.jpg" style="width:231px;height:45px;">&#160;</p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">dilution; absence of dividends; the impact of general business and economic conditions; protection of our intellectual property and avoiding intellectual property infringement; retention of key personnel; manufacturing risks; and other factors described in our filings with the Securities and Exchange Commission. We cannot guarantee that the results and other expectations expressed, anticipated or implied in any forward-looking statement will be realized. A variety of factors, including these risks, could cause our actual results and other expectations to differ materially from the anticipated results or other expectations expressed, anticipated or implied in our forward-looking statements. Should known or unknown risks materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected in the forward-looking statements. You should bear this in mind as you consider any forward-looking statements. Our forward-looking statements speak only as of the dates on which they are made. EyePoint undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Investors:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Christina Tartaglia<br>Stern IR<br>Direct: 212-698-8700</font><font style="color:#ff0000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"><br></font><font style="color:#0563c1;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">christina.tartaglia@sternir.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Media Contact:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Amy Phillips</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Green Room Communications</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">Direct: 412-327-9499</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0563c1;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">aphillips@greenroompr.com</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;" id="range_b10_f55">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:59.84%;"></td>
    <td style="width:2.82%;"></td>
    <td style="width:17.26%;"></td>
    <td style="width:2.82%;"></td>
    <td style="width:17.26%;"></td>
   </tr>
   <tr style="height:12.95pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img96707757_0.jpg" alt="img96707757_0.jpg" style="width:231px;height:45px;">&#160;</p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:59.84%;"></td>
    <td style="width:2.82%;"></td>
    <td style="width:17.26%;"></td>
    <td style="width:2.82%;"></td>
    <td style="width:17.26%;"></td>
   </tr>
   <tr style="height:12.95pt;word-break:break-word;white-space:pre-wrap;">
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:bottom;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><img src="img96707757_1.jpg" alt="img96707757_1.jpg" style="width:483px;height:469px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img96707757_0.jpg" alt="img96707757_0.jpg" style="width:231px;height:45px;">&#160;</p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><img src="img96707757_2.jpg" alt="img96707757_2.jpg" style="width:526px;height:414px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img96707757_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img96707757_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ 3$# 2(  A$! Q$!_\0
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MYT,SN.7!V;2?]H;2#^=?4,/^HC_W1_*IJQ<813\Q25DC&\9_\B/KO_7A/_Z
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&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img96707757_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img96707757_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *_ M0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/;K7#^#;C8W@28:K;:F\-Q-#_9L2 2V:ONW2,5.3@#^( <T+^OQ!GMMKXO\
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M5EKFF6=DCV^IVJ %!G:(G*Y!..>#VIVUL*^ESTNBBBD,**** "BBB@ HHHH
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MQ-/KUQJ,.HRP17EI=1QX'F\9C*J""#V.::7]?-K] _K^OO/6!%&LK2K&@D8
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M2K<A>C,AP WN*BB^'-G!964*7\[3PZFNJ7%S*H9[B4=<XP /ITKM**%I_7S
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN"RIG"Y]A1X(\/S^&O#$-C=R))>-))/<O&<JTCL6.,]N<4(&=%1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !13)9%AA>5L[44L<>@KF/#/Q!T7Q3I5_J-I]H@BL1NF6Y0*P7;N#<$\
M$ _E0!U5%<]X5\9:;XMTN;4+-+BWAAE,3BZ4(<X!SP3Q@BMTSPA58RQA6Y!W
M#!H DHJ,SQ!E7S4W,,J-PR?I6/X7\36_B?25OHHC 3++&(G<%OD<J3^E &Y1
M6+X@\1IX?B$C:9J5ZH1I'-G"'$:CJ6)('X=:SM2^(6C:=X4MO$?EWMQI]P@D
M1H("2%) ^;. O) Y- '5T4V-Q)&LBYPP!&?>G4 %%%% !1110 4444 %%%%
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MLB7"!6#IC/ )]:VJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU))992.FYF;)Q3Z_(70[6BL+_A-?"O\ T,FD?^!L?^-'_":^%?\ H9-(_P#
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MDG!H N457BO[.X:-8;N"0R*60)(#N ."1Z@'BJ<NNVD5S"#/:_9)(GD-R;E
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MC529;9V"AX_XNHP3CL:QO!&EW-BE]<_9/[/TZ[:.2TT_SO,\@;>3QPN>/E'
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M8:C)J%M9JEU)NR^YCC<<G:"<+D]< 4(&:E%%% !1110 4444 %%%% !1110
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MJ\MHY9&N)2P!QT4=!_6N=TN^-WX8O=0.NW;>()+2Y:2Q%UGRG&>%B_AVX&"
M/QS3EI?R!:V/2J*\TO/%'VP(--U<RE/#D\\GDS9VR@)ACCHPY]ZM2V%WGPM9
M_P!N:IC4&>2[D%R0\G[G=M!_A&1VZ46_K[_\A7_K[O\ ,]!HKRV[U'5Y/$.I
M6Z:K#:W-I>Q16J7.I&(&(!#S%M(DW@MR<G)[8J5I]1AAFUDZM?M+'X@^R) 9
MCY0B,P0J5[\$\GIQC%"UM_7;_,;T_K^NQZ3%/#.9!%*DAC<H^Q@=K#J#Z'GI
M4E<1X'M+2SUSQ+&M]</=#49,V\UTSX0JA#["??&ZLC6]?F3Q2LEG?7,3PZK#
M9O%+>[0P)4,%@ ^9<-G<3FA=/,'U\CTZBO-H]5DBU/6+1]<+74T5S)!?)=[X
M;=0< 20_\LRN0,XYP:I2>(+E-$@MK>YE15U%+>^NGU,O&08RPV7&"54D '@$
M$XXH ]2DN(87B225$>5ML:LP!<XS@>IP"?PJ2O)KBW:X?0KC5=:)M(]7E2.>
MVU-G$<9A8A6EXRP;C/7!QFM^SU+[/X^:VGU![T74S);+!>DBW"QY*20^G!(?
MG)(H!G=4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG^-'_"3:#_T&M._\"D_QK5HH RO^$FT'_H-:=_X%)_C1_P )-H/_ $&M._\
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M-R[P,E<\TZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB@ HHHH **** "BBB@ HHHH XSQU9IJEL]E)H>J7CF$_9IK.7:@D/0.-P'!
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M37A\30V4HM[.SF2-H#/&Y-T67)".#M# \;3DFKVL>$M-UJXGFN'NHFN(!;W
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M1/X<UEK:YU9K2-]2N-6@OVLHYA\L<8"A-YP"V!GTS0OZ^_\ R!_U]W^9K?\
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MDV@R1D89!@@[,9]J-0\6>,M0\2ZP-&<QQ:;<)''"\UO%$Z8!W2"3YSN!."I
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MUF6Z-I:03:JR0)%+F+<54%4) SEL]!US27UK8:OXRT^VTVWMXSI=T;R]ND0
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M^ Z?_%UU5% '*_\ "<P_] +6O_ =/_BZ/^$YA_Z 6M?^ Z?_ !==510!RO\
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ME_LVW\1!5>W>5PD7E9.UC\^W)//H36IITS?:[==-FN'T7^WXULW9W8,GDG>
M6Y*[\^U>HX'I1@4+3^O3_(;_ *_'_,\GL;5[VPL[!UE:*73-3S$K, S><-O3
MO5C1WABT?PFF@R$L(9Q(H=B//%OT;/HV..U>H8HP/2CI;^NO^8=;_P!=#R#0
MI);JU\S^W%M+K^SI1J B:>2<.5'SNK#"LK9Z>^*[+P#=PW&F744$$82"8)]H
M@E>2*X.T?,A?D>A'KW-=;@>E&,=* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO3ID59T[0UTS5;^\AO)S#>R><]JP78LA !8'&[G:.,XI+S_K;_@C?]?C_P
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M'CI^G:=X8MHG%O);[O/RI?:,$;%P,#&>:+Z7';H>GTV66.&)Y976.- 69V.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M(KF5X(&D2WDG8=(XBH9OIN('ZUG_ -KWG_0OZG_WW;__ !VM6B@#*_M>\_Z%
M_4_^^[?_ ..T?VO>?]"_J?\ WW;_ /QVM6B@#*_M>\_Z%_4_^^[?_P".T?VO
M>?\ 0OZG_P!]V_\ \=K5HH RO[7O/^A?U/\ [[M__CM']KWG_0OZG_WW;_\
MQVM6B@#*_M>\_P"A?U/_ +[M_P#X[1_:]Y_T+^I_]]V__P =K5HH P[N[>_M
MFMKOPQ?SP-@M'(;<J<'(X\WU J+46CU>V%MJ'A.\NH0VX)+]G8 ^O^MKH:*
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M\^"1SQTJEIN@:WX2D0V%@NIB;3(K239,L?E31ECD[L90[STYXZ4:V_KS_P"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M73II96N2%++% \@0,<+N*@A<^^*1/%&E2ZG)81S2O+&S([K;N8PRC)7?C;D
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MH **** "BBB@ HHHH *QK+PY:VUK?V4X2YLKJZ:Y6"1,A"Q#$>XW9;\:V:*
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MX1?K_C1_PC6C?\^$7Z_XT :M%97_  C6C?\ /A%^O^-'_"-:-_SX1?K_ (T
M:M%<EK#>$=!8+J%ML^3>Q2"20(N<;F*@A1[FG:DOA/2EMS<6RNUR"T,<$4DS
MNHY+!4R<<CGWH ZNJ.L:>VJZ+>Z>EP]NUS"T0F3JF1C(K!O_ /A$]-BM7N+0
M[KI=\,4<$CR,N,D[%!8 9&<CBM#^Q?#XL?MK64:0>7YI9U92%QGD'D<=J&M
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M'.,9('KZUZI)IEA-;+;26-L\"G*Q-$I4'U QBI%L[99(Y%MX0\2[(V"#*+Z
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MKS=?_P"?/3/_  *D_P#C='FZ_P#\^>F?^!4G_P ;H U:*RO-U_\ Y\],_P#
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MG\S7@<_8M,S_ -?4G_QNCJF'1HX[7-0BO/&.D&SU5[^:#45#:.T.WR>"K2Y
M##;R<L2#GZ50OCK$7C31KZ^T"Z^TSZL^V031%?*6&145?FR, ECG')/M7H'F
M:]G/V+3,^OVJ3_XW2^;K_P#SYZ9_X%2?_&Z%H#-6BLQ)==WKOM-."9^8K=.3
MCV_=UIT %%%5;QK]=GV&&VDZ[_/E9,>F,*<T 6J*RO-U_P#Y\],_\"I/_C=
MFU\C(M-,/_;W)_\ &Z -6BLKS=?_ .?/3/\ P*D_^-T>;K__ #YZ9_X%2?\
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M">2P>6.S2*)8]RMQO8ACDD=N *ZOSXO^>J?]]"F!)14?GQ?\]4_[Z%'GQ?\
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M_P#%5T]% ',?\*^\-?\ /C)_X$R__%4?\*^\-?\ /C)_X$R__%5T]% ',?\
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MX$R__%5T]% ',?\ "OO#7_/C)_X$R_\ Q5'_  K[PU_SXR?^!,O_ ,573T4
M<Q_PK[PU_P ^,G_@3+_\55S3/">C:/>"[L;5XY@I7<9G;@]>"2*VZ* "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
/ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img96707757_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img96707757_2.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )M Q4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_D>JT5YW\/\ 4M035KC2?$%UJRZXL'FRV]X4>%QNQYD+*/N\XQ7HE !1110
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M- QLQWQGVJE-\2'LK344O]&:WU/3[BWAGM?M 92LS *ZN!R.3V'2CR_KI_P
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M:,LMS>V,=\R2WBQ85CC:F1\[#TXH6H'?T4@Y )&/:EH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH @O;6.^L;BTESY<\;1MCKAA@_SKB+#P=X@7PS)X3U"_TZ711;/;)/
M'&XN&0@A<@_*"..><XKOJ*+!<X&V\'^(;Z70K?7K_3FL-&D66(6B.)+AT7:A
M?=PN.I SFL_4?AA>W7ABRL8+ZVBOX9Y#+(=VR2%YO-VGC.00I'N#ZUZ=13;"
MQYW=>"_$K7GB."SOM,AT[7)0TDKJ[31+L"$*O"Y(!ZFDC\!ZAI?BI]1TZVT.
MZM#;VT$?]H*S2PB%=N5(4X)^O:O1:*2T!ZGF^K_#:\U'P]J5M#>6T6H3W]Q<
M02G=M$4PVLC<9Y'Z@5-K?@75M:N=.B>328H+)H6CODC<7<80#*J>A!(/)/0]
M*]"HH6G]=@_K[SSS1_!.KZ3JNJOY&A2P7US/-]K9'^U1K(,;0=N/U]:9HG@7
M7DM/#^FZS>Z=_9VB2+-&EHKEYW7.W<6P !G. .:]&HH6G]=@>IRGB'PYJEQX
MDT_Q%H=S:QW]K"]O)#=JWERQL<]5Y!!%4IO#?B>#Q!'XBL;S2FU*:T^RWD,R
M2"$@,64H1ELC..>OM7<44 <#IOP\GLI=*EN+R&ZDCO;F\U!BA42M-&5(1>>!
MD=>U0:5X"UC0XM;CM[C2[V.\DB6&&^C=D,"*5"/CN!@9&>E>BT4 >96'PUU3
M2+;3KS3[^R35+&\FN8H&1_LJI* &B7^( 8R#^E2:E\/M9U2QUB[N;ZQ;6]1G
MMI/E#K!$D+ J@X+'OSBO2:* .*N/#6O:MK6EZGJ<NFQ2VEO=0.ELSE2)54*1
MN';!S69I'@7Q"EAH.FZK>Z;]@T1Q-"EJ'+SR*#LWE@-H!.>!S7I%% 'F$7PM
MU"WM+"\BUV=M:M[_ .WN'D_T8R,V9,+MW#*DBNH7PU<_\);K>KF:'R=0T^.U
M1!G<K+NR3QT^85?F\3Z5;:C?6=Q<"(V$"3W,K\1Q*Q(4%O7C.*O/J5E'=6UJ
M]U$L]TK-!&6&Z0 9)4=\ BBUU;^NP=?Z]3S:T^'6N1>!;WPT\7A^$S6@A6\M
MT<2R,&!!D.WD=?6NDTKPWK$OB6VUS7[FR,EE;-;6MO9*VQ=V-S,S<DG &,5U
M]%.^MP\CA?%?@W5/$VLV\A;2H;:">.6*]6-Q>1!2"54C@Y(/.>_2M$^'=1A\
M5:YK=K<6X:]T^*VMU?.4D3=\S<=/F'2NIK%A\6:)<74%M%?!II[B6VC78PS)
M$,NO3C'KTJ;=/Z[!Y_UW.0T[X87.BS>'KVQUJYEO--EW3I<RYA9''[T( N02
M3D9K7E\'7DDGC)OM$ &NHJP=?W>(MGS<>OIFNOAFBN(EEAD22-N5=&!!^A%$
MTR6\$DTK;8XU+L?0 9--[.X+?0\WC\!:U)X4BT26'0+3R9+5Q-9(ZM-Y3 DO
M\HR2!^9JK=?":ZD7Q$L5_ 4O64:>DF[;;(91+(#QW8=J[RQ\4Z5J-_:VEK,[
MM=VGVRW<H0LD><'&>_(XK9I];_U_6@O(X&R\':MIWC/4-7BM]"N8+RY242W"
M.;B%0@4A#MP#P>]9^H_#"^N_"]I8P7UM%?PW$IDD(;9)"\WF[#QG((4CW!]:
M].HI#.<;P]<GQW#KZS1""/36L]ASNWEPV?3''K61H_@W4X?&R^(K]M+MG2%X
MG738W0W1;'S2YXR,=L]>M=U10!QE[X:U^Q\4ZEK7AV[T\#4XHTN8KU7^1T&%
M="O7CL:RK?X4VJS:!%?-!?V6GQ7'VE9E(,TLK!MP X SGO7I%% '.^+/"XU_
MPXFFVDRVDUM)%-:N5W*CQD%01W'&*P;WP7KOB"YNK_6[S3UNQITUE:0VBOY:
M&089V9N3VX KT"BAZ@<%/\-K2+X=76@:9;V-KJ-U9QPS7(0@2.N,DG&<9!_.
MJ]WX#U#5]&LM,O[+0+6WM]0AN9(K%'5)D4$,&&T?,>*]%HH>KN'2QYK_ ,*U
MO_L0T&/4(K?0$U/[;&("5G6/&0F2I&0^#DYX%:.F>!;W24\36D.IM<V6KQ;H
MC=.6E28H5=F(4 @\=.>*[FBE;2P=;G%_\(9>&S\&P&X@SH;JTYY_> 1%/EX]
M3WQ60/A]KZ^'I?"2ZG8#P]).6\WRW^TB(OO,>/N]>-WZ5Z7157UN&QP.H_#^
M>[M]=\FY@BN+JYCN+"0@GR2L0CPWL0"#CL:HZI\/=8U+PUIF@L^C&&UMHHA>
M/$_VBW=?O-$1USVSBO3**0#(8S#!'&7+E%"[FZG ZFGT44 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSMA\1+^\M?#\HTV)Y-4>\5HT8Y'DAMH7/<[>_K56#XEWLGAU[N>/2K;4!<B
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH **** "BBB@ HHHH **KO?V<=TMJ]W MPV,1-( YSTXSFK% !1110 4444
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MU1XM_E0Q)G)!(SN.3VXK8_X5[HO_ #\ZU_X.+K_XY1_PKW1?^?G6O_!Q=?\
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M*):/9(DT@*K"V,KP!_='/7U)I/\ A#-/=;C[3<WMT\]O';L\LHRJQMN0KM
M(/.?;G-']?G_ , /Z_+_ ()#J6K:_;ZMHENMI:1"YN)(YD^TE@ZB)F&#Y>1T
M]!R,=#FKVN^(!HMQ8PM#'BZ9E\V>7RHU(QA2V#\QSP#C.#S4DN@+/]D>;4+V
M2XM9C-%<$IN!*E2,;=N"">U2ZQHT6MVIM9[FXCMW4I+'$5Q*IZ@Y4_F,'WH
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M @CL+MH(FLEL9%DB$NZ-<X(ST/S'/4'CCB@#HK6226S@DF0)*\:LZ*<A6(Y
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ";=)&>?ED7 *-[<]>M;5 !1110 4444 %%%% !1110 4444 %%%% !1110
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MR^';2:6[EEEN'DNK,64K%QDH-W/3K\Q_PJS!K6F7(B,-_;OYSF./;(/F8#)
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M+'%.[F:0$I%%$\KD#J=J@G'(YINH:WIVEI:M?7(@^URK#"&4Y=VZ#&,C\>E
M%^BLR?Q#I=M>FTEN=LJNL;$1L41V^ZK.!M4G(P"1U'K6G0 4444 %%%% !11
M10 4444 %<SXAVW'B70K&[ .FS^<9$;[DDJJ-BMV/!8X/4BNFJ&ZM+:]@,%W
M;Q3PD@F.5 RG'L: .;N)O)UR/0]-NTTRT2SDN=\"(<N' *C<"H SD@#N.E9U
MCXDU:=M(O+^1X+*]BBC!MEC($S$CYU;+ -\I4KT[UUKZ-I<EM';OIMFT$1S'
M&T"E4/L,8%2MIUB]U'=-9VYN(AB.4Q+O0>@.,B@#G_ D<L7AMWDNYK@_:KG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*.'"]78G=CA03T]*Z*LK^QV?Q(FJS3^8D-MY%O%M^X2<NQ.>2<*/P/K6K1T
M**** "BBB@ HHHH **** "J6H:I;Z:L0FWO+,VR&&)=SR-C. /H.IX%7:Y_7
M;&[_ +;TO5[:![E+59H9H8V ?;(%^9<D#(*CN.": -2#4HI+62XN(Y;-8VP_
MVH!,>^<X(Y[&I)+^SAC626[@1&&Y6:0 $>H/I7"SZ1KUR8[B7^T#9P:D98X'
M>.2<0^5M!P^Y3AR3@\XZ59L_"WE:OI[_ &*:2SBL+I,W?EED>216"X7@<9P
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MO3)O$6D6Z6#2:A"!J#*EK@Y\TMTQCMR.:PO.>UU^RU9K.]DLWTPVWR6LA=)
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\^,D\DXY_"D2X6T\27^MG6=)F26V6$6T;@.0A=EPQ?&26QZ5U7V*U_Y]H?\
MOV*/L5K_ ,^T/_?L4 <M<7MQJFAK:7>N:'"]S;>7= $-M9@=VWY\=#W[BDU.
M.TO]*_L5=?TM-,:)(6W.&F"J #AMV,G'7'%=5]BM?^?:'_OV*/L5K_S[0_\
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M!Y5D\LLEK:QV<LK*9&,:\_-Z@@<\<TNIZ%J\UWK%OI<,L4=]!,SR7*QX24J
M#$X);#8Y!&!^E=\\B1*&D=4!( +'')Z"G4 M#SO4-,%KX0UV8PW\4][:QVJQ
MW2PH"_*H%6, 9RP&3[>E=K8HJ7=T!8&%P(P]R54?:/EZY!R<=.<>U7)88IPH
MEC20*P=0R@X8<@CW%/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHS,2K!VZ[2I!7CCCM0M@>YS<"7U[X1G98KV^N+::[M[=TO#$0JNP1F.X;B,
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MK=95 \M4P >_R@@^M']?E_P0&7GC73;'46M)5<&)HDF;>@\II,;05+;CU&<
MXS725SEEX3CTR[,MG=D1R+$)EFB61F,:A0P8]"0HSP>G:NCH **** "BBB@
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MMD=B$;"MM."#_#UZU9N+._OO#_A[0I; VZ3K']O6,$I#%&H)3//WB%7&>F:
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M2 :O^'+ZUU'0;6XLA.L!!0)<$F1"I*E6))R001U/2@!/[*OO^AAU'_OU;_\
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M_:VGY8?;K?*F,$>8.-_W/^^NWK5R@ HIJ2)(NY'5ER1E3D9'6E) !). .IH
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M2V, G(QD\]JLWVJV>G/$ES*5>7.Q%1G8@=3A03@9&3T%<Z_A2[^S:G"DT/\
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M_P L&!?MWQQ_2G)X:U6.^M8U>T^PP:J]_O+-YCJ^X[=N, @L><G(]*I[_/\
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M#"L;_A%]8_Z&:X_[XD_^.5U5% '*_P#"+ZQ_T,UQ_P!\2?\ QRC_ (1?6/\
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04 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>eypt-20240508.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2024-05-07T18:19:24.1636+00:00 -->
<!-- Copyright (c) 2024 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://eyepointpharma.com/20240508" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:eypt="http://eyepointpharma.com/20240508" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="eypt-20240508.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139948325328384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>May 08, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  08,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EyePoint Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001314102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-2774444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">480 Pleasant Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Watertown<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(617)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">926-5000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EYPT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    ( *4XJ%AED'F2&0$  ,\#   3
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " "E.*A8)!Z;HJT   #X 0
M&@              @ ',$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " "E.*A899!YDAD!  #/ P  $P              @ &Q$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #[$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="eypt-20240508.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="eypt-20240508.htm">eypt-20240508.htm</File>
    <File>eypt-20240508.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "eypt-20240508.htm": {
   "nsprefix": "eypt",
   "nsuri": "http://eyepointpharma.com/20240508",
   "dts": {
    "inline": {
     "local": [
      "eypt-20240508.htm"
     ]
    },
    "schema": {
     "local": [
      "eypt-20240508.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_5180bc99-5889-4922-9124-48a80e5659ce",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eypt-20240508.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5180bc99-5889-4922-9124-48a80e5659ce",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "eypt-20240508.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://eyepointpharma.com/20240508/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000950170-24-055055-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-24-055055-xbrl.zip
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M!J:G4<,'+^"AZ;O.:CFFC?^>9.?IU3H#.;^CUY(5.,8C7+*N\?>>L"<,KAF
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M:8" ECOBU2&G[#8C>(3]9(0EX[HL0IF:7LEV,HPG9/9!_ES+; 5((G<H8N*
MO5I$D<@]_Q8U+,76M0Q6[%1]=R=#>4$=.L4?.@SV[WTQ-]O_4:#G9/M#Z'E&
M8)K4L#5&+1YI-#!D\K_N!QP-(=.QM66-I]\S42"*98K)**D2)O+[\=P@3>.
M(4442)?+ /K3C[YK6?N/&5 O1685.A"ID_@@PXE#@V<C-&\LPZY8YLYA07E&
M<%=W2?O3&3%,K8$5;T7^C-LAGD&\SJL@7M_5(@M<@_+0"M&E\M&;<@R7.DYH
M>^!97LCYLL3;0PT6(MZ3BR.Y2R-8_'8I]Q879% AXS[9ZA:CNC%!N5-G6V_H
MUD*S5=5\FZ1K& &+'!W*3&;+U6P:(#$B)3-P0\OS(G=ITCW-0,I<>16/NEY
MZO'L)(K0?7VS)(PXH>$$4AZ5PKK%J;$;O'L:09=UWR9).RYSF>$&U#!,G5IZ
M%%%F1$C7IL4]/=*P%%9,TMT\'T&V)>QG$;8)U)*7'CZ%L*NZ]PE[Y?<Z^-_@
M7H=GZ[];&ZQT:R!#QV@XZ[8')3(J-P>QV7H% 2SSH;-I#YUXT^UG-K3L=6R@
M/#='^FX P[@)8+QLGL(Z@LPJA?U<W@%9WA41]DD8LSR?%8A;)2;)CY'ZT<PW
MD^KRUDCK/&,2(^7E<^,!UMU=51+#EJ[>,%TI@CJN[AE0$@MJ<P45+O:-W]QJ
MY6^77OO:4VIU&[AI62[5;2VB5LA=RB*=4S?R+=/T/9^SI1/>*L-IK!N!4CJ+
MD\G<P#9:N;C\O2(-O^X1-(/()8M'0/X+UT#3M[F:*Q(T&TBWH(5(<A%0L#6#
M6N!$--!,C7+#L"W7Y(&E+;WM7^FR4HVMCF@[_W=ZOB7-[Y<T;? #KND!U320
MI!G9U-<"H+;A>H'K:-SVER;-6J36/KNZ0NE>]$.JR.>FQ\\U\-"E/68Y9W^1
MSW$:L)@<L>SK0D=\GKFW__B%C(O1[+>)S'03+J,P0((Q"=4^+$[S*UHLH ZI
MW]DD%3G!"0+B[D+&V2^R]*KHRV#.4&Z<LIQPB$127JE4;A-I]HP+)6_OD33)
MKF0W=U]FR)G^OMHQJMO@:$@^0WDGD\PR* -#1D"-)]Y1>;=O&2NZ;3[1>V-S
MMG77>R7KR]%99P[-/'(QLAQN7D37X.!&7*=1""&U=,^BOA^XU+,UV[?QMQ^M
MZ,Q//??/:NKM<N8O'\S]O@FF&ST@:O90P,R46^)>7D<?I1+$$!8HE9)4Q4%'
M.:A:"&:5/2)?-!$J-EJ^>2#75HT5C^7@5P*'EM2:X+2Q)(-+D6.[Z.8-'A:&
M\MHE65F^X,)9QO,R;X3/"\*:N^PF"#LIO1I/X8G%"&A-M[1-._BS7VW8I"2J
MB7VN*(9KRD56+H8,/X\&R7[]V(LLW;_W;,6_1GDAHG$]BJI%D8#V)]^SZ&>W
M!N(%E X[NJRH95HLOF+CO(HI+_Y Q@.6QZ,WJ:\K[VO%6QC= @;$:&B&?+AJ
M%!?J^-$)LF2U382,-?'N53M%&2 +&O,(?7(WTVK8IOE05N$R#PZ\G)@\28B\
M%+BZ$WB//'Q%*-F5TD;:0X:V7RDR]4G??X?&73Y"8<50;LF37QG(0_* 2$]0
MM(4JXPY7Y%;F9=4:25DIN_UKI.[/)*5,1;,[[!-3+R>FEBY$_XBA99@JTU(D
M-V](-<@A2MOA3>K=] 304(M&62+ROIR=-/7Z(A %\?V&3K G*-*Y%/!6F,9'
M#W3R23AY^EANM)8\4V$L?PZ:7H@K5HPD>;']$ECX3@XC3*98RU?0]E>WN3N5
MP:'Z7FJ[UV_XUC/W;3WD!><I6[?>^J/JU4GRNN+-R;0[1]$>" UYSR=$'9M.
MFVCZO:3W;[I)4@ONXREYO=PA_9FH73DJ7S+ J+AU \GKKOW_PL3U$?(P$T-U
MF^)F;J\M0*IKU3]+1%>ER?42K/M];@Z\) (8F7@H$ZY]_T^]T2\&\TDEBAXX
M#L@AK"XM;:F$/?E6[$/)@+E\FKBT[M'D?]AGV2/RJ14^Z>;<H)]MF7SU3*YK
MUI;'OP<>7UD6 \)%3MD%(#^B%F?J@73YE#DKK^/=A4$ 7#K],E"*#K[TX<7$
M@^F\>DYI>UW(]QR&7&1%JL.J&YM+W?U\?'C^VUFGMY+0XG*8>;G@XN13@>6V
MRE\C)-8RL/2T/=B]6?LQ?!2/2<A&<@]%;<26#\#)80(@.0*-!6FBXHT!]%D<
MR6T>V9&R+JH*,O0W2K"-ZHZ-BGZ:(;C\;GQG$]/9G8<2SQ^*?#Q8]J2PQ[>R
MA-Z2EM_"^I9AM1J+O9A6UE]#H'Q^2E_G]*1[?$Y.?SD\.SIL=WX[[[8/O_30
MP3INSXS%+7E'S%9F;&'=POK:8'TU1L.B G>=WK%\&;BUR=IFG<#/BLF],13\
M<[RVZQK7=OSJ]6&YF3?)9T@S="Y/&J03Y\7&;O.\7OF_A74+ZT*P-MS%;D]8
M56AK'@KN20AY*O/VTO+_%2$0N?LD9-A.94:U^P*BB<2I\E[S;!NGWJPX]4$S
M2/GXPP\'S7XQB#_\!U!+ P04    " "E.*A8E,2OA&D(  !870  $0   &5Y
M<'0M,C R-# U,#@N>'-D[5Q;;]LV&'W?K^#4EQ:K+-EIVL:H4WA.,QA+DR!.
ML6+#4,@2;1.528V2$OO?CY1$W4S)CAU)=N ]K*KT\? <\2)^IZ0_?5[,;?
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M!L]K&7YL[S?:R\R=4.\ JW#&1SA:@SUB-IPOM!N-M;I,;8V)]BZ K:DHV[?
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MSF>M&8.FH)K'/)#EI.0]Q$6GT"KN"B4>3#(CTB^Z]><S0>^#\4S+PFP0*(\
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M11=5%02KB#L4ET54,H7Y$5YS15=F#VD4[Z)U7:"OB*U=NWPB!D+]!)?4NQQ
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M6WXSTV"PDQN)ZGHL 3THKEH%6<)6%;CJS>*F80I75**EEK0IOQ 4CV!J&/D
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MN!A'VMEO/-_^R0;;TG#-.^W&\_9'7FGM-=J[=S$,?M#+^_-!O'9C?P?G0[E
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M   /              "  < :  !E>7!T+65X.3E?,2YH=&U02P4&      ,
, P"[    <#,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>eypt-20240508_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="eypt-20240508.xsd" xlink:type="simple"/>
    <context id="C_5180bc99-5889-4922-9124-48a80e5659ce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001314102</identifier>
        </entity>
        <period>
            <startDate>2024-05-08</startDate>
            <endDate>2024-05-08</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_07502e19-034f-4e84-b7dc-e88619825f3a">0001314102</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_7fa45e2a-6039-44c6-87e7-8d5516872c03">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_558eae15-2714-42e0-8d78-6d5943c628cb">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_0eaf18ad-fc07-4612-9f2e-77c68199b5ac">2024-05-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_c2d5b467-e2da-4b97-b16a-87be4f688284">EyePoint Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_c015c280-1d5a-4227-9de6-0f926a37802f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_1a4721f6-528c-45e3-a314-c1d2e0da2a95">000-51122</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_71b400c7-e391-4a86-82ac-312c02100bab">26-2774444</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_ce19a4dd-648b-4886-8591-8d87ff61c534">480 Pleasant Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_51d5d8d9-fd9f-43b9-b380-29e8bdc39764">Watertown</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_e73be44e-6b9a-4250-983f-d76d0cba35ea">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_5997b360-fdcb-40ac-8a4b-317b229d3ae8">02472</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_61645bdb-b121-4fd9-8d00-9a5acfc554f7">(617)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_d8b40ce1-0f3d-443c-a3ad-f6f58fc8d34f">926-5000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_ec882b33-250a-4df0-b267-e19bde563650">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_970f4e72-dc4c-4f90-9627-66c58e848cdd">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_22baf61e-a314-4705-b492-dcae7c488f7d">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_67a7a27b-2231-41ff-a2f5-b34d81f0a7ae">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_15ed3447-150f-4cd7-af1d-7f9433989da8">Common Stock, par value $0.001</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_e0c124fe-e502-4e6f-b030-d225473db40f">EYPT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_5e9bd01b-00e2-4ef5-90be-5278b760d59f">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_5180bc99-5889-4922-9124-48a80e5659ce"
      id="F_62de7fd1-fcec-4184-99b7-8505958509fa">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
